Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN8A | Q9UQD0 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29864603 | 1.00 | SCN8A (0.35) | SCN8AMAPTL3MBTL1LMNASMN1; SMN2 | |
| SCHEMBL26963249 | 0.96 | SCN8A (0.35) | SCN8ALMNAKDM4EMEN1ALDH1A1 | |
| SCHEMBL15065311 | 0.94 | SCN8A (0.33) | SCN8A | |
| SCHEMBL16333319 | 0.93 | SCN8A (0.32) | SCN8AMAPTL3MBTL1 | |
| SCHEMBL15783301 | 0.93 | MAPT (0.38) | SCN8AMAPTL3MBTL1LMNAKDM4E | |
| SCHEMBL29113982 | 0.91 | GRIN2D (0.37) | SCN8AMAPTLMNAKDM4EALDH1A1 | |
| SCHEMBL18925382 | 0.90 | SCN8A (0.32) | SCN8AMAPTL3MBTL1KDM4EMEN1 | |
| SCHEMBL28452195 | 0.89 | SCN8A (0.31) | SCN8A | |
| SCHEMBL29990583 | 0.87 | L3MBTL1 (0.38) | SCN8AMAPTL3MBTL1LMNASMN1; SMN2 | |
| SCHEMBL15847866 | 0.87 | L3MBTL1 (0.38) | SCN8AMAPTL3MBTL1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565508-B2 | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-03-03 | — | — | US | disclosed |
| EP-3925989-B1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-07 | — | — | EP | disclosed |
| US-12497414-B2 | Group III and Lanthanide bis-phenyl-phenoxy metal-ligand complexes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-12-16 | — | — | US | disclosed |
| EP-4097151-B1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20240150502-A1 | BIPHENYLPHENOL POLYMERIZATION CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-05-09 | — | — | US | disclosed |
| EP-4332133-A2 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | Dow Global Technologies LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| EP-4291585-A1 | BIPHENYLPHENOL POLYMERIZATION CATALYSTS | Dow Global Technologies LLC (US) | 2023-12-20 | — | — | EP | disclosed |
| US-20230183267-A1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-15 | — | — | US | disclosed |
| US-20230183267-A1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-15 | — | — | US | disclosed |
| US-20230183267-A1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-15 | — | — | US | disclosed |
| WO-2014105414-A1 | A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-07-03 | — | — | WO | disclosed |
| WO-2014105414-A1 | A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-07-03 | — | — | WO | disclosed |
| WO-2014105412-A1 | AN ETHYLENE BASED POLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-07-03 | — | — | WO | disclosed |
| US-20140163186-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-06-12 | — | — | US | disclosed |
| US-8609794-B2 | Process for selectively polymerizing ethylene and catalyst therefor | DOW GLOBAL TECHNOLOGIES, LLC. (US) | 2013-12-17 | — | — | US | disclosed |
| EP-2491062-B1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-12-11 | — | — | EP | disclosed |
| EP-2491062-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | Dow Global Technologies LLC (US) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011146291-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-24 | — | — | WO | disclosed |
| WO-2011146044-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565508-B2 | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | SCO2, CBR3, SOD1 | SCN8A 3853/4885MAPT 4465/4885L3MBTL1 738/4885 |
| US-12497414-B2 | Group III and Lanthanide bis-phenyl-phenoxy metal-ligand complexes | SSB, SOD1, LGALS3 | SCN8A 3396/4885MAPT 1303/4885L3MBTL1 358/4885 |
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | WEE2, NOTUM, WEE1 | SCN8A 4256/4885MAPT 1699/4885L3MBTL1 3645/4885 |
| US-20230183267-A1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | SSB, SOD1, LGALS3 | SCN8A 3359/4885MAPT 1428/4885L3MBTL1 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.